logo
Demand for weight loss drugs is becoming unsustainable, say pharmacists

Demand for weight loss drugs is becoming unsustainable, say pharmacists

The Guardian19 hours ago
Demand for weight loss drugs is becoming so 'unsustainable' that demand may soon outstrip supply, pharmacists have warned.
The National Pharmacy Association (NPA) said supply problems could encourage people to turn to unregulated online sources, despite the risks involved.
The number of people in the UK using drugs such as Wegovy and Mounjaro has soared to well above a million, with most patients paying to get them privately.
During April, 1.6m packs of Mounjaro and Wegovy were bought in Britain, with the number thought to correlate closely with the number of people using them.
'Spiralling demand for weight loss medication risks going far beyond what is clinically deliverable', the NPA said.
The drugs might need to be reserved for those in greatest need because they are so overweight instead of being given to the 'worried well', it added.
New polling has found that 21% of Britons have tried to get hold of the medications over the past year, a figure that rises to 35% among 18- to 34-year-olds.
The same survey found that 41% of all age groups would use them if they were free on the NHS. This figure rose to 64% among those aged 25-34.
Savanta interviewed a representative sample of 2,002 adults aged 18 or over online from 20-23 June for the NPA, which represents 6,000 independent pharmacies.
'Weight loss jabs are one of the biggest drug innovations this century but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it,' said Olivier Picard, the NPA's chair.
'It's clear from this polling that more people are interested in getting weight loss jabs than can benefit from weight loss medication.'
Supply of the medicines has been hit by shortages in some parts of the UK, including for higher doses of Mounjaro, the NPA said. Supply has been restricted to some pharmacies, which has stopped some new patients from going on to the drugs.
The Medicines and Healthcare products Regulatory Agency, the UK's drugs watchdog, has warned patients to obtain the drugs only with a doctor's prescription, and not from beauty parlours or websites.
A Department of Health spokesperson said more people would be able to obtain 'revolutionary' weight loss jabs over the next few years.
'Weight loss drugs are a powerful tool in tackling the obesity crisis head-on as part of our 10-year health plan', they added.
'This government is committed to ensuring that more people have access to these revolutionary drugs when needed, and crucially that they are able to do so in a safe and controlled way. We will ensure that those most in need will receive treatment first.'
About 220,000 people in England are due to be offered tirzepatide, a diabetes drug that promotes weight loss, over the next three years.
Pharmacies already provide about 85% of all weight loss drugs and need to be closely involved in the expansion of access, Picard added.
'The government should use the massive untapped expertise and skills of pharmacists to help speed up the NHS's weight loss medication programme to millions of the most in need patients,' he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warning as weight loss drugs could go out of stock over demand
Warning as weight loss drugs could go out of stock over demand

Scotsman

time10 minutes ago

  • Scotsman

Warning as weight loss drugs could go out of stock over demand

Pharmacies have warned that the demand for weight loss medication risks going far beyond what is clinically deliverable 🚨 Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... More than one in five people have attempted to access weight loss medications according to a recent poll. Pharmacies have described the current demand for medications 'unsustainable'. Many patients interested in accessing weight loss medications are not eligible. Pharmacies have issued a stark warning about the 'unsustainable' demand for weight loss drugs. More than one in five people in the UK have attempted to access weight loss medications through a pharmacy last year, with the National Pharmacy Association (NPA), explaining that the demand 'risks going far beyond what is clinically deliverable'. Advertisement Hide Ad Advertisement Hide Ad New polling commissioned by the NPA, who represent over 6000 independent community pharmacies, and carried out by Savanta found that: 21% of the public agreed that they had attempted to access weight loss treatments in the last year through an online or in person pharmacy. This rose to 35% of 16 to 34 year olds, compared to only 7% of those over 55. Whilst, 41% agreed that they would access weight loss treatments on the NHS if it was made available to them, rising to 64% of 25 to 34 year olds. However, the NPA warned that many patients interested in using the medication are not eligible to do so. Pharmacies have warned that spiralling demand for weight loss medication risks going far beyond what is clinically deliverable. | Illustration byOlivier Picard, Chair of the National Pharmacy Association said: 'Weight loss jabs are one of the biggest drug innovations this century but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. Advertisement Hide Ad Advertisement Hide Ad "It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Who is eligible for weight loss medications? Weight loss medications Mounjaro and Wegovy are licensed by The Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 and with one weight related co-morbidity. However, the NHS are only rolling out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities. Advertisement Hide Ad Advertisement Hide Ad Could weight loss drugs go out of stock? The demand for weight loss drugs like Mounjaro and Wegovy could have a negative impact on stock. If this continues to soar, this could potentially lead to medication shortages. The NPA have warned that the demand for weight loss medication risks going far beyond what is clinically deliverable.

Bedfordshire woman with ME criticises health plan for condition
Bedfordshire woman with ME criticises health plan for condition

BBC News

time11 minutes ago

  • BBC News

Bedfordshire woman with ME criticises health plan for condition

A woman living with myalgic encephalomyelitis (ME) said she has "lost faith" in receiving "meaningful support" after the government released a new support plan for the also known as chronic fatigue syndrome (CFS), is a neurological disease which affects about 390,000 people in the UK. On 22 July the government launched a new delivery plan to improve education around the illness, as well as increase funding, research and medical training for health practitioners. Maddie Walker, 51, from Bedfordshire, said she was "disappointed" in how the plan lacked any "real change to improve the quality of life for sufferers". Ms Walker said she was healthy and active before she developed severe ME and was now unable to leave the house without a wheelchair and has carers visit her multiple times a described living with the condition as "mind-numbing" and that she felt "despondent". The condition's symptoms include fatigue, muscle and joint weakness, cognitive dysfunction and post-exertional malaise. Misdiagnosis Ms Walker was initially diagnosed with fibromyalgia with fatigue, a condition causing muscular pain all over the body. As a result of the crossover in symptoms, Ms Walker's ME was not recognised initially, leading her to be recommended treatment that was not tailored to both conditions."Something I feel really strongly about is people being given the right information at the point of diagnosis because if I had known what I was doing was harmful, I might not be in this situation."Ms Walker said she has a "terrible, really poor quality of life" and that "hundreds of thousands of people have once again been let down" by the new delivery plan. "We just aren't important enough," she said. The ME Association (MEA) said the government must go "much further" to improve medical care and funding for "much needed" biomedical research. It added that currently most research studies for ME/CFS are funded by the charity added there were numerous strengths to the plan, including the approach to broaden education about the illness in the NHS and in schools. Dr Charles Shepherd, a medical adviser with the MEA, said the plan does not align with the 2021 National Institute for Health and Care Excellence guidelines, which suggested making referral services more accessible in hospitals. Ashley Dalton, the MP for West Lancashire and minister for public health and prevention, said: "[The] plan will help tackle the stigma and lack of awareness of this condition through improved training for NHS staff." A spokesperson of Department for Health and Social Care (DHSC) said: "We acknowledge there is more to be done and will continue to build on the foundations of these actions well beyond the publication of this plan."There was a "clear commitment" to achieving "meaningful change" for the ME/CFS community, it using neighbourhood health services, the DHSC said it will ensure patients can access quality care closer to home. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.

Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency
Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency

The Independent

timean hour ago

  • The Independent

Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency

President Donald Trump 's hand makeup is back as he meets with world leaders between games of golf on his trip to Scotland. Photographs of the president's meeting with European Commission President Ursula von der Leyen on Sunday showed the back of his right hand apparently caked in concealer. It was also evident on Monday, ahead of his meeting with U.K. Prime Minister Sir Keir Starmer, and on Friday as he departed the White House on Marine One. Trump, 79, has persistent bruising on his hand that has previously been attributed to the large number of handshakes he gives and receives in his role as president and an aspirin regimen, though that has done little to quell speculation on social media. The bruising was acknowledged in a July 17 medical report that also diagnosed Trump with chronic venous insufficiency (CVI), a benign and common condition, prevalent in people over the age of 70. The apparent need to cover the bruising with makeup has not been explained. As the oldest president ever to be elected and take office, Trump's health and mental acuity have been a concern since his inauguration in January, though the White House is adamant he 'remains in excellent health.' In February, during a visit to the White House by President Emmanuel Macron of France, a large bruise was noticed on the back of Trump's right hand, sparking speculation about its cause. More recently, the use of makeup was noticed in photos, and questions were also raised about what appeared to be swelling around his ankles during his attendance at the FIFA Club World Cup Final. Shortly after, Press Secretary Karoline Leavitt released a letter from the White House physician confirming that a doctor had seen the president for a 'comprehensive examination,' the conclusion of which was the diagnosis of CVI — a condition in which veins struggle to manage blood flow, making it hard for blood to return to the heart. The report by Sean Barbabella, the president's physician, also noted: 'Recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store